Δ9-Tetrahydrocannabinol inhibits electrically-evoked calcitonin gene-related peptide release from capsaicin-sensitive nerves
Cannabinoids have wide-ranging effects on the cardiovascular system not all of which are mediated through the cannabinoid receptors CB1 and CB2. Zygmunt et al (2002) have shown that Δ9-tetrahydrocannabinol (THC) causes the release of calcitonin gene-related peptide (CGRP) from capsaicin-sensitive sensory nerves in rat isolated mesenteric arteries, resulting in a potent vasodilation that can not be blocked by CB1/ CB2 antagonists, and is likely to involve a TRP type ion channel. It has also been shown that THC attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed (Duncan et al, 2004). This was observed as an inhibition of vasorelaxation following electric field stimulation (EFS) of capsaicin-sensitive sensory nerves, and was unaffected by CB1/CB2 antagonists. In the present study we investigated directly the effect of THC on EFS-induced release of CGRP from sensory nerves, by assaying perfusate levels of CGRP, and investigated the possible involvement of cannabinoid receptors and TRP channels.
We show for the first time that THC inhibits the EFS-induced release of CGRP from perivascular capsaicin-sensitive sensory nerves by directly measuring CGRP release; this evoked release can not be blocked by CB1/CB2 antagonists but is abolished by ruthenium red, suggesting the involvement of a TRP ion channel.
Duncan M et al, (2004) J Pharmacol Exp Ther 331, 411-419